GRAIL, Inc. (NASDAQ:GRAL) President Sells $503,984.00 in Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) President Joshua J. Ofman sold 9,692 shares of the firm's stock in a transaction on Monday, June 30th. The stock was sold at an average price of $52.00, for a total value of $503,984.00. Following the completion of the sale, the president directly owned 492,076 shares of the company's stock, valued at $25,587,952. This trade represents a 1.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

GRAIL Stock Down 1.6%

Shares of GRAL traded down $0.75 during trading on Friday, reaching $46.81. 1,042,680 shares of the company traded hands, compared to its average volume of 1,195,085. The stock has a 50-day simple moving average of $40.59 and a 200-day simple moving average of $32.56. The stock has a market cap of $1.68 billion and a PE ratio of -0.77. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, beating the consensus estimate of ($4.03) by $0.93. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. The firm had revenue of $31.84 million during the quarter, compared to the consensus estimate of $35.80 million. On average, equities research analysts predict that GRAIL, Inc. will post -15.15 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on GRAL shares. Morgan Stanley increased their price target on shares of GRAIL from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group lifted their target price on GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

Institutional Investors Weigh In On GRAIL

Several institutional investors and hedge funds have recently modified their holdings of GRAL. Caldwell Sutter Capital Inc. purchased a new stake in GRAIL during the first quarter worth about $28,000. KBC Group NV increased its stake in GRAIL by 187.7% during the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after buying an additional 933 shares during the period. S.A. Mason LLC increased its stake in GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after buying an additional 500 shares during the period. State of Tennessee Department of Treasury acquired a new stake in GRAIL during the 4th quarter worth approximately $28,000. Finally, Lindbrook Capital LLC purchased a new position in GRAIL in the 4th quarter valued at approximately $28,000.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.